Fullerene derivatives for medical applications

AIP Conference Proceedings

Volumn 786, Issue , 2005, Pages 581-585

  Hirsch, Andreas ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Antioxidants; Enzyme Inhibitors; Fullerenes; Medical Applications

Indexed keywords

EID: 33749680410     PISSN: 0094243X     EISSN: 15517616     Source Type: Conference Proceeding    
DOI: 10.1063/1.2103935     Document Type: Conference Paper

References (18)

1. Friedman, S. H., DeCamp, D. L., Sijbesma, R. P., Srdanov, G., Wudl, F., and Kenyon, G. L., J. Am. Chem. Soc. 115, 6506-6508 (1993).
2. Sijbesma, R. P., Srdanov, G., Wudl, F., Castoro, J. A., Wilkins, C., Friedman, S. H., DeCamp, D. L., and Kenyon, G. L., J. Am. Chem. Soc. 115, 6510-6512 (1993).
3. Friedman, S. H., Ganpathi, P. S., Rubin, Y., and Kenyon, G. L., J. Med. Chem. 41, 2424 (1998).
4. Wilson, S. R., "Biological Aspects of Fullerenes," in Fullerenes, Chemistry, Physics and Technology, edited by K. M. Kadish and R. S. Ruoff, Wiley Interscience, pp. 437-465, (2000).
5. Brettreich, M., and Hirsch, A., Tetrahedron Letters 39,2731 (1998).
6. Quaranta, A., McGarvey, D. J., Land, E. J., Brettreich, M., Burghardt, S., Schoenberger, H., Hirsch, A., Gharbi, N., Moussa, F., Leach, S., Goettinger, H., and Bensasson, R.V., Phys. Chem. Chem. Phys. 5, 843 (2003).
7. Schuster, D. I., Wilson, S. R., Kirschner, A. N., Schinazi, R. F., Schlueter-Wirtz, S., Tharnish, P., Barnett, T., Ermolieff, J., Tang, J.,Brettreich, M., Hirsch, A., Proc. - Electrochem. Soc., 2000-11, 267-270 (2000).
8. Chiang, L. Y., Wang, L.-Y, Swirczewski, J. W., Soled, S., and Cameron, S., J. Org. Chem. 59, 3960 (1994).
9. Okuda, K., Hirobe, M., Mochizuki, M., and Mashino, T., Proc. Electrochem. Soc. 97, 337 (1997).
10. Lincoln, J., Hoyle, H. V., and Burnstock, G., Nitric Oxide in Health and Disease. Cambridge University Press, Cambridge (1997).
11. Satoh, M., Matsuo, K., Kiriya, H., Mashino, T., Hirobe, M., and Takayanagi, I., Gen. Pharmacol. 29, 345 (1997).
12. Lamparth, I., and Hirsch, A., J. Chem. Soc., Chem. Commun. 1994, 1727.
13. Reuther, U., Brandmüller, T., Donaubauer, W., Hampel, F., and Hirsch, A., Chem. Eur. J. 8, 2261 (2002).
14. Dugan, L. L., Turetsky, D. M., Du, C., Lobner, D., Wheeler, M., Almli, R., Shen, C. K. F., Luh, T. Y., Choi, D. W., and Lin, T. S., Proc. Natl. Acad. Sci. USA 94, 9434 (1997).
15. Grayson, M., Lovett, E., Dugan, L., Wang, Y., and Gross, M., Abs. Am. Soc. Mass Spectrosc. 1999, 929.
16. Anderson, D. K., Dugan, L. L., Means, E. D., and Horrocks, L. A., Brain Res. 637, 119 (1994).
17. Dugan, L. L., Lovett, E., Cuddihy, S., Ma, B.-W., Lin, T.-S., and Choi, D. W., "Carboxyfullerenes as Neuroproteclive Antioxidants," in Fullerenes, Chemistry, Physics and Technology, edited by K. M. Kadish and R. S. Ruoff, Wiley Interscience, pp. 467-479 (2000).
18. Lotharius, J., Dugan, L. L., and O'Malley, K. L., J. Neurosci. (1999).